483 Response Valeant Pharmacueticals North America Jun 2014

Frank Marciniak FDA$119.00 - Available Now

FDA investigators audited the Valeant Pharmacueticals North America - Rochester, NY, United States facility and issued inspectional observation (via FDA 483) on 26 Jun 2014.

Product details

  • Category:
  • Inspection end: 26 Jun 2014
  • Location: Rochester, United States
  • FEI: 3009443653
Add To Cart